(Q39199929)

English

Expression of angiogenesis-related gene profiles and development of resistance to tyrosine-kinase inhibitor in advanced renal cell carcinoma: characterization of sorafenib-resistant cells derived from a cutaneous metastasis

scientific article published on 4 February 2013

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Expression of angiogenesis-related gene profiles and development of resistance to tyrosine-kinase inhibitor in advanced renal cell carcinoma: characterization of sorafenib-resistant cells derived from a cutaneous metastasis (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

0 references

renal cell carcinoma

1 reference

based on heuristic

inferred from title

3

object named as

Kenji Tamura

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

author name string

Takashi Karashima

1

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Hideo Fukuhara

2

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Shingo Ashida

4

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Masayuki Kamada

5

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Keiji Inoue

6

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Takahiro Taguchi

7

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Naoto Kuroda

8

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Taro Shuin

9

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

publication date

4 February 2013

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

International Journal of Urology

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

923-930

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

describes a project that uses

0 references

Metastatic tumors of the skin.

1 reference

https://api.crossref.org/works/10.1111%2FIJU.12084

21 January 2018

Sorafenib in advanced clear-cell renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FIJU.12084

21 January 2018

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FIJU.12084

21 January 2018

Discovery of a novel Raf kinase inhibitor

1 reference

https://api.crossref.org/works/10.1111%2FIJU.12084

21 January 2018

In vitro cultivation of human renal cell cancer. II. Characterization of cell lines

1 reference

https://api.crossref.org/works/10.1111%2FIJU.12084

21 January 2018

Conventional and molecular cytogenetic characterization of a new human cell line, GIST-T1, established from gastrointestinal stromal tumor

1 reference

https://api.crossref.org/works/10.1111%2FIJU.12084

21 January 2018

STI571 (Glivec) inhibits the interaction between c-KIT and heat shock protein 90 of the gastrointestinal stromal tumor cell line, GIST-T1.

1 reference

https://api.crossref.org/works/10.1111%2FIJU.12084

21 January 2018

Multicolor Spectral Karyotyping of Human Chromosomes

1 reference

https://api.crossref.org/works/10.1111%2FIJU.12084

21 January 2018

Spectral karyotyping, a 24-colour FISH technique for the identification of chromosomal rearrangements

1 reference

https://api.crossref.org/works/10.1111%2FIJU.12084

21 January 2018

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1111%2FIJU.12084

21 January 2018

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis

1 reference

https://api.crossref.org/works/10.1111%2FIJU.12084

21 January 2018

Kinase inhibition with BAY 43-9006 in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FIJU.12084

21 January 2018

EAU guidelines on renal cell carcinoma: the 2010 update

1 reference

https://api.crossref.org/works/10.1111%2FIJU.12084

21 January 2018

Active chemotherapy for sarcomatoid and rapidly progressing renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FIJU.12084

21 January 2018

Sarcomatoid renal cell carcinoma: biologic behavior, prognosis, and response to combined surgical resection and immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FIJU.12084

21 January 2018

Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial.

1 reference

https://api.crossref.org/works/10.1111%2FIJU.12084

21 January 2018

Cutaneous metastases in renal cell carcinoma: a case report

1 reference

https://api.crossref.org/works/10.1111%2FIJU.12084

21 January 2018

The Heidelberg classification of renal cell tumours.

1 reference

https://api.crossref.org/works/10.1111%2FIJU.12084

21 January 2018

Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FIJU.12084

21 January 2018

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

1 reference

https://api.crossref.org/works/10.1111%2FIJU.12084

21 January 2018

Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function

1 reference

https://api.crossref.org/works/10.1111%2FIJU.12084

21 January 2018

Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein

1 reference

https://api.crossref.org/works/10.1111%2FIJU.12084

21 January 2018

Clinical response to therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: impact of patient characteristics and Von Hippel-Lindau gene status.

1 reference

https://api.crossref.org/works/10.1111%2FIJU.12084

21 January 2018

Identifiers

10.1111/IJU.12084

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39199929&oldid=1822347145"